- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01914315
Rehabilitation Program in Heart Failure With Preserved Ejection Fraction
Multi-Disciplinary Rehabilitation Program in Recently Hospitalized Patients With Preserved Ejection Fraction Heart Failure
The purpose of this prospective study is to determine whether comprehensive cardiac rehabilitation is superior to usual disease management in the treatment of patients with heart failure with preserved systolic function (HFpEF) recently discharged after an acute heart failure event.
The investigators hypothesize that the addition of bi-weekly structured exercise training and interaction with medical personnel will lead to a greater reduction in all cause hospitalization and mortality while providing additional functional and clinical benefits such as exercise capacity, quality of life and well-being.
Furthermore the investigators seek to establish clinical, laboratory and echocardiographic predictors of hospital readmissions and cardiovascular events in the predefined HFpEF population.
연구 개요
상세 설명
Our primary objective is to test the hypothesis that comprehensive multi-disciplinary cardiac rehabilitation program is superior to usual care in the treatment of patients with HFpEF discharged after an acute heart failure event, and will result in a 25% reduction in the composite outcome of all cause hospitalizations and all-cause mortality after 1-year of follow-up. This objective represents both safety and efficacy end-point in a patient population with a high rate of co-morbidities, which may be affected as well. Previous observation has shown that these patients have a high rate of non-cardiac death in comparison with HFrEF, thus enhancing the importance of all-cause hospitalization and mortality as a primary end-point.
Secondary end-points that will be recorded include separate components of the primary end-point, time to first hospitalization, functional capacity measured by NYHA class, 6-minute walk test (6MWT), blood pressure during rest and exercise, fasting glucose and Hb A1C levels, BNP values and quality of life EQ5-D questionnaire.
연구 유형
등록 (예상)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Ramat Gan, 이스라엘
- 모병
- Sheba Medical Center
-
연락하다:
- Nava Levine Tiefenbrun, Dr.
- 이메일: Nava.LevineTiefenbrun@sheba.health.gov.il
-
Tel Hashomer , Ramat Gan, 이스라엘
- 아직 모집하지 않음
- Sheba Medical Center, Cardiac Rehabilitation Institute
-
연락하다:
- Robert Klempfner, MD
- 전화번호: +972525506852
- 이메일: klempfner@gmail.com
-
연락하다:
- Merav Moreno, Msc
- 이메일: Merav.Moreno@sheba.health.gov.il
-
부수사관:
- Robert Klempfner, MD
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Patients >=21 years of age willing and able to sign consent forms
- Hospitalization for acute heart failure (AHF) in one of the internal medicine departments participating in the study
AHF as the primary diagnosis as defined by:
- (I) The presence of pulmonary congestion or edema on chest radiography OR
- (II) Evidence of fluid retention (pedal edema, pleural effusion, ascites) not otherwise explained by other conditions (i.e. malignancy, nephrotic syndrome, liver cirrhosis, severe hypo-albuminemia, etc) AND
(III) Echocardiography demonstrating the presence of preserved systolic function
- In cases where diagnosis is unclear BNP testing (with a cutoff value of >300 ng/dl) will be used.
- If there is clinical suspicion of pulmonary disease investigators are encouraged to perform pulmonary function tests after the patient condition is stabilized.
- Preserved systolic function as determined by in-hospital or recent (within 3 months) echocardiographic examination according to ESC guidelines and in the absence of hemodynamic significant valvular disease.
- Stable clinical condition prior to discharge permitting the initiation of an exercise training program
Exclusion Criteria:
- Hemodynamically significant valvular disease (severity > mild other than TR)
- Acute coronary syndrome as the primary diagnosis
- End stage heart failure - NYHA IV
- Severe renal dysfunction - eGFR<30 ml/min/1.73m2 or renal replacement therapy
- Inability to participate in an exercise program and comply with study protocol
- Severe chronic obstructive pulmonary disease (COPD) (FEV1<50%) or asthma defined as severe
- First episode of a hypertensive crisis event (without history of chronic heart failure)
- Cognitive decline or major psychiatric pathology
- Non ambulatory condition
- Life expectancy < 12 months
- Substance dependency
- Inability to participate due to technical barriers such as a significant distance from a cardiac rehabilitation center
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Cardiac Rehabilitation
Patients randomized to the multidisciplinary cardiac management program at the cardiac rehabilitation center will undergo evaluation by a trained rehabilitation physician and physiologist.
The evaluation will include medical history, physical examination, vitals, review of post discharge graded exercise stress test and nursing staff consultation.
Exercise prescription will be based on a pre-specified protocol in accordance with ESC position paper on cardiac rehabilitation of patients with heart failure.
|
Patients will participate in a 6-month cardiac rehabilitation program, consisting of structured, 60-minutes, bi-weekly exercise training sessions according to a predefined protocol.
Institutional activity will be complemented by 120 minutes weekly home exercise prescribed by specialist in cardiac rehabilitation.
Exercise prescription will be based on a symptom limited exercise test when clinically feasible and according with the patients' functional capacity, medical history and physiological values obtained prior to exercise.
Target heart rate will be set initial as 50-60% of heart rate reserve and gradually increased up to 80% of HRR.
Aerobic exercise will be complemented by resistance training of low intensity.
다른 이름들:
|
활성 비교기: Internal Medicine
Following discharge, patients will return to the internal medicine (IM) outpatient clinics at 2-4 weeks, 3, and 6 months for consultation.
These scheduled consultations will comprise of history taking, recording of any new events, physical examination and recommendations as clinically indicated.
|
Following discharge, patients will return to the IM outpatient clinics at 2-4 weeks, 3, and 6 months for consultation.
These scheduled consultations will comprise of history taking, recording of any new events, physical examination and recommendations as clinically indicated.
Target values for blood pressure and glucose control will be in accordance with current guidelines and special emphasis given to management of fluid retention.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Combined primary endpoint
기간: 12 months following randomization
|
Combined all-cause mortality and hospitalizations at a 12-months follow-up
|
12 months following randomization
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Secondary endpoint - change in functional capacity and clinical status
기간: 3 and 6 month follow-up after randomization
|
Secondary clinical outcomes will be collected during the 3 and 6 month follow-up visits and will include: blood pressure averages , HbA1C levels, assessment of NYHA class and global clinical assessment , 6-minute walk test and quality of life data as evaluated by the EQ-5D questionnaire
|
3 and 6 month follow-up after randomization
|
All cause mortality end-point
기간: 12 months after randomization
|
12 months after randomization
|
|
Heart failure hospitalizations
기간: 12 months after randomization
|
Number of HF hospitalizations as assessed by HF specialists blinded to patients allocation.
Assessment will include medical record and hospital discharge letter review.
|
12 months after randomization
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Stankovic I, Neskovic AN, Putnikovic B, Apostolovic S, Lainscak M, Edelmann F, Doehner W, Gelbrich G, Inkrot S, Rau T, Herrmann-Lingen C, Anker SD, Dungen HD. Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly. Int J Cardiol. 2012 Nov 29;161(3):160-5. doi: 10.1016/j.ijcard.2012.06.004. Epub 2012 Jun 21.
- Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC; Get With the Guidelines Scientific Advisory Committee and Investigators. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012 Jul 3;126(1):65-75. doi: 10.1161/CIRCULATIONAHA.111.080770. Epub 2012 May 21.
- Lewis BS, Shotan A, Gottlieb S, Behar S, Halon DA, Boyko V, Leor J, Grossman E, Zimlichman R, Porath A, Mittelman M, Caspi A, Garty M; HFSIS Investigators. Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel Nationwide Heart Failure Survey. Isr Med Assoc J. 2007 Apr;9(4):234-8.
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
심부전에 대한 임상 시험
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan University of... 그리고 다른 협력자들아직 모집하지 않음심부전, 수축기 | 박출률이 감소된 심부전 | 심부전 New York Heart Association Class IV | 심부전 New York Heart Association Class III폴란드
-
Novartis Pharmaceuticals완전한핵심 연구의 12개월 치료 기간을 성공적으로 완료한 환자(de Novo Heart Recipients)는 EC-MPS 치료에 관심이 있었습니다.
-
University of WashingtonAmerican Heart Association완전한심부전,울혈 | 미토콘드리아 변경 | 심부전 New York Heart Association Class IV미국
Cardiac Rehabilitation에 대한 임상 시험
-
Medtronic Cardiac Rhythm and Heart Failure완전한
-
Uskudar State Hospital아직 모집하지 않음폐 질환 | 폐 재활 | 원격 의료
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic International Trading Sarl완전한
-
Uppsala University HospitalMedtronic; Swedish Heart Lung Foundation알려지지 않은
-
Boston Scientific Corporation모집하지 않고 적극적으로빈맥, 심실 | 부정맥, 심실미국, 스페인, 이탈리아, 영국, 네덜란드, 프랑스, 체코, 오스트리아, 캐나다
-
Medtronic Cardiac Rhythm and Heart Failure완전한
-
Respicardia, Inc.완전한